VRNA Verona Pharma Inc.: Business Value

Verona Pharma Inc. - graphic logo of issuer VRNA

The Verona Pharma plc (VRNA) price chart reflects a business valuation that currently stands at . Verona Pharma plc operates as a lean scientific team, outsourcing its production and testing. The firm maintains significant authority in treating lung diseases by implementing cutting-edge therapeutic methods. However, the brand's financial stability relies solely on a single inhalation product, creating a critical dependency on its market success.

VRNA (veronapharma.com) Total Company Value history from 07/04/2022 to 10/29/2026

Verona Pharma plc (VRNA) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Performance Chart Verona Pharma PLC|VRNA - Price Target Chart
- market capitalization data:
Market Capitalization Verona Pharma|VRNA - Enterprise Value
- book capitalization data:
Book Value per Share Verona Pharma|VRNA - Company Book Value|Market Capitalization to Net Assets veronapharma.com|VRNA - Company Total Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Verona Pharma plc|VRNA - Long-Term Debt to Capital|Short-Term Debt to Capital veronapharma.com|VRNA - Company Debts|Debt to Net Assets Ratio Verona Pharma|VRNA - Company Long-Term Debt|Company Current Liabilities Verona Pharma
Comprehensive company analysis:Verona Pharma PLC (VRNA)
Original product of Verona Pharma plc

The dynamics of this multiple allow for an objective assessment of the business's investment value by combining market capitalization with net debt to determine the actual cost of acquiring the asset. By analyzing the total enterprise value including net debt, an investor sees the actual price of Verona Pharma (VRNA), which is critically dependent on external contractors (CRO/CMO) due to a lack of in-house manufacturing capacities.

Competitor analysis for Verona Pharma plc

Haleon PLC - Value Adjusted for Debt and Cash|Kenvue Corp (KVUE) - Total Company Value|MENS - Business Value|LGND: Enterprise Value|AMRX (amneal.com) - Enterprise Value|Total Company Value Perrigo PRGO|Full Business Value Alvotech S.A.|Liquidia Technologies (LQDA) - Enterprise Value|Value Adjusted for Debt and Cash Galapagos Corp (GLPG)|Enterprise Value ANIP (ANI Pharmaceuticals)|mannkindcorp.com - Enterprise Value|Total Company Value Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX: Value Adjusted for Debt and Cash|SPRY (ARS Pharma) - Total Company Value|Theravance Corp (TBPH) - Real Price to Acquire Entire Company|AQST (Aquestive Therapeutics) - Enterprise Value|Enterprise Value scPharma (SCPH)|Tectonic Therapeutic, Inc. (TECX) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash TNXP (Tonix Pharma)|SXTC: Total Company Value|EPRX - Total Enterprise Value|Real Price to Acquire Entire Company BioHarvest Sciences BHST|EXOZ - Aggregate Business Value|Enterprise Value oramed.com ORMP|Entera Bio (ENTX) - Value Adjusted for Debt and Cash|Enterprise Value HYFT (MindWalk)|Total Enterprise Value ABVC|Cumberland Pharmaceuticals (CPIX) - Total Company Value|Value Adjusted for Debt and Cash quantumbiopharma.com QNTM|Real Price to Acquire Entire Company FibroGen FGEN|Total Company Value Telomir Pharmaceuticals Inc TELO|RANI (Rani Therapeutics Inc) - Enterprise Value|SNYR: Total Enterprise Value|Total Company Value rallybio.com RLYB|LEXX (Lexaria Bioscience Corp.) - Value Adjusted for Debt and Cash|Total Company Value PULM (Pulmatrix)|Total Enterprise Value PTHL|Total Company Value Aptorum Group Limited APM|Business Value Lyra Therapeutics Inc (LYRA)|Enterprise Value IBO (Impact BioMedical)|TNFA - Enterprise Value|Real Price to Acquire Entire Company cbdMD Corp (YCBD)|PRFX: Value Adjusted for Debt and Cash|Total Company Value altamiratherapeutics.com (CYTO)|Lipella Pharma (LIPO) - Full Business Value|OPTN - Enterprise Value|Value Adjusted for Debt and Cash pieris.com|Enterprise Value PROC|Enterprise Value PTPI (Petros Pharmaceuticals Inc)|Total Company Value Qilian International Holding Group Limited|ACELYRIN Inc. - Value Adjusted for Debt and Cash|TFFP: Total Company Value